Novo Nordisk A/S ADR buy Quitte
Start price
15.08.16
/
50%
€42.14
Target price
15.02.17
€44.65
Performance (%)
-26.05%
End price
15.02.17
€31.16
Summary
This prediction ended on 15.02.17 with a price of €31.16. The prediction for Novo Nordisk A/S ADR disappointed with a performance of -26.05%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 0.506% | 0.506% | -28.478% | -69.441% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by Quitte for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
übertrieben
sooo schrecklich waren die Zahlen nicht
Analysten bleiben positiv
(Laufzeit überschritten)